Fig. 4.
Lytic lesion in the left calvarium with 68Ga-DOTA-F(ab′)2-trastuzumab uptake (patient 1). 68Ga-DOTA-F(ab′)2-trastuzumab, 68Ga-1,4,7,10-tetraazacyclododecane-N,N′,N′′,N′′′-tetraacetic acid (DOTA)-F(ab′)2-trastuzumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.